A Promising Cutaneous Leishmaniasis Treatment with a Nanoemulsion-Based Cream with a Generic Pentavalent Antimony (Ulamina) as the Active Ingredient

A Promising Cutaneous Leishmaniasis Treatment with a Nanoemulsion-Based Cream with a Generic Pentavalent Antimony (Ulamina) as the Active Ingredient

Leishmania parasites are the etiological agents of Leishmaniasis, a tropical disease that affects around 15 million people in about 90 countries. The chosen therapy for this disease is based on antimony V compounds, such as meglumine antimoniate. It can be administered as a parenteral, subcutaneous...

Full description

Bibliographic Details
Main Authors: Johnny Bullón, Laura Márquez, José Alejandro Fernández, César Scorzza, José Vicente Scorza, Jimmy Rodríguez, Atilio Cordero, Francia Véjar, Sonia Koteich-Khatib, Ana Forgiarini
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cosmetics
Subjects:
nanoemulsions
cutaneous leishmanisis
meglumine antimoniate
ulamina
transdermal passage
Online Access:https://www.mdpi.com/2079-9284/8/4/115

Similar Items

Similar Items